SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    L. Vanneste, P. Wolter, J.J. Oord, M. Stas, M. Garmyn, Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients., Journal of the European Academy of Dermatology and Venereology, 2014, 28,
  2. 2
    Madeleine Schönherr, Animesh Bhattacharya, Tina Kottek, Silke Szymczak, Margarethe Köberle, Claudia Wickenhauser, Udo Siebolts, Anja Saalbach, Dirk Koczan, Thomas M. Magin, Jan C. Simon, Manfred Kunz, Genomewide RNAi screen identifies protein kinase Cβ and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis, Pigment Cell & Melanoma Research, 2014, 27, 3
  3. 3
    Jeong-Hun Kang, Protein Kinase C (PKC) Isozymes and Cancer, New Journal of Science, 2014, 2014, 1

    CrossRef

  4. 4
    Katharina Limm, Susanne Wallner, Vladimir M. Milenkovi, Christian H. Wetzel, Anja-Katrin Bosserhoff, The metabolite 5′-methylthioadenosine signals through the adenosine receptor A2B in melanoma, European Journal of Cancer, 2014,

    CrossRef

  5. 5
    Fabien Binamé, Transduction of Extracellular Cues into Cell Polarity: the Role of the Transmembrane Proteoglycan NG2, Molecular Neurobiology, 2014,

    CrossRef

  6. 6
    Françoise Silvy, Jean-Claude Lissitzky, Nadine Bruneau, Nathalie Zucchini, Jean-François Landrier, Dominique Lombardo, Patrick Verrando, Resistance to cisplatin-induced cell death conferred by the activity of organic anion transporting polypeptides (OATP) in human melanoma cells, Pigment Cell & Melanoma Research, 2013, 26, 4
  7. 7
    Simona Romano, Giovanna Nappo, Gaetano Calì, Samuel Y.-S. Wang, Stefania Staibano, Anna D'Angelillo, Gennaro Ilardi, Antonio Sorrentino, Anna Laura Di Pace, Maria Siano, Rita Bisogni, Maria Fiammetta Romano, Synergy between enzastaurin doxorubicin in inducing melanoma apoptosis, Pigment Cell & Melanoma Research, 2013, 26, 6